- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/635 - Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide having a heterocyclic ring, e.g. sulfadiazine
Patent holdings for IPC class A61K 31/635
Total number of patents in this class: 1355
10-year publication summary
|
107
|
98
|
119
|
97
|
128
|
161
|
121
|
137
|
116
|
52
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| scPharmaceuticals Inc. | 40 |
21 |
| Dana-Farber Cancer Institute, Inc. | 2654 |
18 |
| Mayo Foundation for Medical Education and Research | 3354 |
15 |
| Ascentage Pharma (Suzhou) Co., Ltd. | 221 |
14 |
| Novartis AG | 10341 |
13 |
| The Johns Hopkins University | 5829 |
13 |
| The Regents of the University of California | 20587 |
12 |
| Board of Regents, The University of Texas System | 6062 |
12 |
| Dogwood Therapeutics, Inc. | 15 |
12 |
| Genentech, Inc. | 4087 |
11 |
| AstraZeneca AB | 2828 |
11 |
| Ascentage Pharma Group Corp Limited | 143 |
11 |
| Merck Sharp & Dohme LLC | 3732 |
11 |
| Boehringer Ingelheim Vetmedica GmbH | 1272 |
10 |
| Centre National de La Recherche Scientifique | 10895 |
10 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3148 |
10 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3331 |
9 |
| Rigel Pharmaceuticals, Inc. | 509 |
9 |
| The Regents of the University of Colorado, a body corporate | 2783 |
8 |
| Esteve Pharmaceuticals, S.A. | 238 |
8 |
| Other owners | 1117 |